125 related articles for article (PubMed ID: 37479061)
1. Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35.
Hansen CR; Jensen K; Smulders B; Holm AIS; Samsøe E; Nielsen MS; Sibolt P; Skyt P; Elstrøm UV; Nielsen CP; Johansen J; Zukauskaite R; Eriksen JG; Farhadi M; Andersen M; Andersen E; Overgaard J; Grau C; Friborg J
Radiother Oncol; 2024 Jan; 190():109812. PubMed ID: 37479061
[TBL] [Abstract][Full Text] [Related]
2. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
3. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
4. PTV-based VMAT vs. robust IMPT for head-and-neck cancer: A probabilistic uncertainty analysis of clinical plan evaluation with the Dutch model-based selection.
Rojo-Santiago J; Korevaar E; Perkó Z; Both S; Habraken SJM; Hoogeman MS
Radiother Oncol; 2023 Sep; 186():109729. PubMed ID: 37301261
[TBL] [Abstract][Full Text] [Related]
5. Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer.
Friborg J; Jensen K; Eriksen JG; Samsøe E; Maare C; Farhadi M; Sibolt P; Nielsen M; Andersen M; Holm AIS; Skyt P; Smulders B; Johansen J; Overgaard J; Grau C; Hansen CR
Radiother Oncol; 2024 Jan; 190():109958. PubMed ID: 37871751
[TBL] [Abstract][Full Text] [Related]
6. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
Heukelom J; Kantor ME; Mohamed ASR; Elhalawani H; Kocak-Uzel E; Lin T; Yang J; Aristophanous M; Rasch CR; Fuller CD; Sonke JJ
Radiother Oncol; 2020 Jan; 142():100-106. PubMed ID: 31431381
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome after pencil beam scanning proton therapy and dysphagia/xerostomia NTCP calculations of proton and photon radiotherapy delivered to patients with cancer of the major salivary glands.
Walser MA; Bachmann N; Kluckert J; Köthe A; Tully C; Leiser D; Lomax AJ; Bizzocchi N; Langendijk JA; Weber DC
Br J Radiol; 2023 Aug; 96(1148):20220672. PubMed ID: 37129312
[TBL] [Abstract][Full Text] [Related]
8. First experience with model-based selection of head and neck cancer patients for proton therapy.
Tambas M; Steenbakkers RJHM; van der Laan HP; Wolters AM; Kierkels RGJ; Scandurra D; Korevaar EW; Oldehinkel E; van Zon-Meijer TWH; Both S; van den Hoek JGM; Langendijk JA
Radiother Oncol; 2020 Oct; 151():206-213. PubMed ID: 32768508
[TBL] [Abstract][Full Text] [Related]
9. Partitioning of discrete proton arcs into interlaced subplans can bring proton arc advances to existing proton facilities.
Engwall E; Marthin O; Wase V; Sundström J; Mikhalev V; de Jong BA; Langendijk JA; Melbéus H; Andersson B; Korevaar EW; Both S; Bokrantz R; Glimelius L; Fredriksson A
Med Phys; 2023 Sep; 50(9):5723-5733. PubMed ID: 37482909
[TBL] [Abstract][Full Text] [Related]
10. An online adaptive plan library approach for intensity modulated proton therapy for head and neck cancer.
Oud M; Breedveld S; Giżyńska M; Kroesen M; Hutschemaekers S; Habraken S; Petit S; Perkó Z; Heijmen B; Hoogeman M
Radiother Oncol; 2022 Nov; 176():68-75. PubMed ID: 36150418
[TBL] [Abstract][Full Text] [Related]
11. Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - From a fixed beam line to an arc.
Amstutz F; Krcek R; Bachtiary B; Weber DC; Lomax AJ; Unkelbach J; Zhang Y
Radiother Oncol; 2024 Jan; 190():109973. PubMed ID: 37913953
[TBL] [Abstract][Full Text] [Related]
12. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
13. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
14. Consistency in contouring of organs at risk by artificial intelligence vs oncologists in head and neck cancer patients.
Nielsen CP; Lorenzen EL; Jensen K; Sarup N; Brink C; Smulders B; Holm AIS; Samsøe E; Nielsen MS; Sibolt P; Skyt PS; Elstrøm UV; Johansen J; Zukauskaite R; Eriksen JG; Farhadi M; Andersen M; Maare C; Overgaard J; Grau C; Friborg J; Hansen CR
Acta Oncol; 2023 Nov; 62(11):1418-1425. PubMed ID: 37703300
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the effect of setup uncertainty reduction and adaptation to geometric changes on normal tissue complication probability using online adaptive head and neck intensity modulated proton therapy.
Lalonde A; Bobić M; Sharp GC; Chamseddine I; Winey B; Paganetti H
Phys Med Biol; 2023 May; 68(11):. PubMed ID: 37164020
[No Abstract] [Full Text] [Related]
16. Automated Robust Proton Planning Using Dose-Volume Histogram-Based Mimicking of the Photon Reference Dose and Reducing Organ at Risk Dose Optimization.
Kierkels RGJ; Fredriksson A; Both S; Langendijk JA; Scandurra D; Korevaar EW
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):251-258. PubMed ID: 30145392
[TBL] [Abstract][Full Text] [Related]
17. Multivariable normal tissue complication probability model-based treatment plan optimization for grade 2-4 dysphagia and tube feeding dependence in head and neck radiotherapy.
Kierkels RGJ; Wopken K; Visser R; Korevaar EW; van der Schaaf A; Bijl HP; Langendijk JA
Radiother Oncol; 2016 Dec; 121(3):374-380. PubMed ID: 27614681
[TBL] [Abstract][Full Text] [Related]
18. Technical note: Evaluation of deep learning based synthetic CTs clinical readiness for dose and NTCP driven head and neck adaptive proton therapy.
de Koster RJC; Thummerer A; Scandurra D; Langendijk JA; Both S
Med Phys; 2023 Dec; 50(12):8023-8033. PubMed ID: 37831597
[TBL] [Abstract][Full Text] [Related]
19. NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy.
Hansen CR; Friborg J; Jensen K; Samsøe E; Johnsen L; Zukauskaite R; Grau C; Maare C; Johansen J; Primdahl H; Bratland Å; Kristensen CA; Andersen M; Eriksen JG; Overgaard J
Acta Oncol; 2019 Oct; 58(10):1410-1415. PubMed ID: 31432744
[No Abstract] [Full Text] [Related]
20. Optimal Allocation of Proton Therapy Slots in Combined Proton-Photon Radiation Therapy.
Loizeau N; Fabiano S; Papp D; Stützer K; Jakobi A; Bandurska-Luque A; Troost EGC; Richter C; Unkelbach J
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):196-207. PubMed ID: 33848609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
